These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
990 related articles for article (PubMed ID: 30854665)
21. Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression. Chen WX; Wang DD; Zhu B; Zhu YZ; Zheng L; Feng ZQ; Qin XH Aging (Albany NY); 2021 Mar; 13(7):10415-10430. PubMed ID: 33752173 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
23. Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis. Liu Y; Tan J; Ou S; Chen J; Chen L J Physiol Biochem; 2019 Aug; 75(3):391-401. PubMed ID: 31321740 [TBL] [Abstract][Full Text] [Related]
24. Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages. Cheng L; Liu J; Liu Q; Liu Y; Fan L; Wang F; Yu H; Li Y; Bu L; Li X; Wei W; Wang H; Sun G Int J Biol Sci; 2017; 13(6):723-734. PubMed ID: 28655998 [TBL] [Abstract][Full Text] [Related]
25. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma. Han K; Zhang Y J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252 [TBL] [Abstract][Full Text] [Related]
26. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma. Fan F; Chen K; Lu X; Li A; Liu C; Wu B Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943 [TBL] [Abstract][Full Text] [Related]
27. Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape. Shang H; Lu L; Fan M; Lu Y; Shi X; Lu H Int Immunopharmacol; 2024 Sep; 138():112282. PubMed ID: 38936058 [TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization. Pei W; Wei K; Wu Y; Qiu Q; Zhu H; Mao L; Shi X; Zhang S; Shi Y; Tao S; Mao H; Pang S; Wang J; Liu M; Wang W; Yang Q; Chen C Gene; 2023 Nov; 885():147692. PubMed ID: 37562585 [TBL] [Abstract][Full Text] [Related]
29. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D. Wang Y; Cao K J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695 [TBL] [Abstract][Full Text] [Related]
30. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885 [TBL] [Abstract][Full Text] [Related]
31. MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. Zhang Y; Zheng L; Ding Y; Li Q; Wang R; Liu T; Sun Q; Yang H; Peng S; Wang W; Chen L Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1132-1140. PubMed ID: 26031366 [TBL] [Abstract][Full Text] [Related]
32. Endometriosis derived exosomal miR-301a-3p mediates macrophage polarization via regulating PTEN-PI3K axis. Huang Y; Zhu L; Li H; Ye J; Lin N; Chen M; Pan D; Chen Z Biomed Pharmacother; 2022 Mar; 147():112680. PubMed ID: 35124383 [TBL] [Abstract][Full Text] [Related]
33. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma. Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782 [TBL] [Abstract][Full Text] [Related]
34. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
35. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1. Guo XL; Wang HB; Yong JK; Zhong J; Li QH Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839 [TBL] [Abstract][Full Text] [Related]
36. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999 [TBL] [Abstract][Full Text] [Related]
37. MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma. Xiang Y; Yang Y; Lin C; Wu J; Zhang X J Physiol Biochem; 2020 Feb; 76(1):123-134. PubMed ID: 31994011 [TBL] [Abstract][Full Text] [Related]
38. Human aortic smooth muscle cell-derived exosomal miR-221/222 inhibits autophagy via a PTEN/Akt signaling pathway in human umbilical vein endothelial cells. Li L; Wang Z; Hu X; Wan T; Wu H; Jiang W; Hu R Biochem Biophys Res Commun; 2016 Oct; 479(2):343-350. PubMed ID: 27644883 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. Tu K; Liu Z; Yao B; Han S; Yang W Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293 [TBL] [Abstract][Full Text] [Related]
40. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Zhu J; Liu B; Wang Z; Wang D; Ni H; Zhang L; Wang Y Theranostics; 2019; 9(23):6901-6919. PubMed ID: 31660076 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]